Under the EC Merger Regulation (139/2004), parties to a merger may offer modifications or "remedies" to the proposed transaction in order to eliminate competition concerns identified by the European Commission (Commission). In the light of recent case law and consultation, the Commission has revised its Notice on acceptable remedies and made changes to the Merger Implementation Regulation (Commission Regulation 802/2004). The new remedies notice introduces a form for submitting information on remedies, provides more stringent requirements on divestiture, details on when access remedies may be permitted and clarification on the role of the Trustee.